{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:48:51Z","timestamp":1780919331693,"version":"3.54.1"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Chemical Neuropathology"],"published-print":{"date-parts":[[1991,6]]},"DOI":"10.1007\/bf03159935","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T23:54:56Z","timestamp":1250812496000},"page":"153-197","source":"Crossref","is-referenced-by-count":446,"title":["Pathology of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03159935_CR1","first-page":"166","volume-title":"Movement Disorders 2","author":"Y. Agid","year":"1987","unstructured":"Agid Y., Javoy-Agid F., and Ruberg M. (1987) Biochemistry of neurotransmitters in Parkinson\u2019s disease,Movement Disorders 2 (Marsden C. D. and Fahn S. T., eds.), pp. 166\u2013230, Butterworth, London."},{"key":"BF03159935_CR2","first-page":"83","volume":"53","author":"Y. Agid","year":"1990","unstructured":"Agid Y., Graybiel A. M., Ruberg M., Hirsch E., Blin J., Dubois B., and Javoy-Agid F. (1990) The efficacy of levodopa treatment declines in the course of Parkinson\u2019s disease: Do nondopaminergic lesions play a role?Adv. Neurol. 53, 83\u2013100.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR3","first-page":"239","volume":"53","author":"A. Albanese","year":"1990","unstructured":"Albanese A., Altavista M. C., Gozzo S., Rossi P., Colosimo C., Bentivoglio A. R., Rerretta G., Elia M., Monaco V., and Macchi G. (1990) Chronic administration of MPTP to marmosets.Adv. Neurol. 53, 239\u2013249.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"R. L. Albin","year":"1989","unstructured":"Albin R. L., Young A. B., and Penney J. B. (1989) The functional anatomy of basal ganglia disorders.Trends Neurosci. 12, 366\u2013374.","journal-title":"Trends Neurosci."},{"key":"BF03159935_CR5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"G. E. Alexander","year":"1986","unstructured":"Alexander G. E., DeLong M. R., and Strick P. L. (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex.Annu. Rev. Neuroscience 9, 357\u2013381.","journal-title":"Annu. Rev. Neuroscience"},{"key":"BF03159935_CR6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-8993(85)91632-4","volume":"337","author":"J. M. Allen","year":"1985","unstructured":"Allen J. M., Cross A. J., Crow T. J., Javoy-Agid F., Agid Y., and Bloom S. R. (1985) Dissociation of NPY and somatostatin in Parkinson disease.Brain Res. 337, 197\u2013202.","journal-title":"Brain Res."},{"key":"BF03159935_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/brain\/109.1.143","volume":"109","author":"J. M. Allen","year":"1986","unstructured":"Allen J. M., Cross, A. J., Yeats, J. C., Ghatel, M. A., McGregor, G. F., and Close, S. P. (1986) Neuropeptides and dopamine in the marmoset\u2014Effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): An animal model for Parkinson\u2019s disease.Brain 109, 143\u2013157.","journal-title":"Brain"},{"key":"BF03159935_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(88)90827-X","volume":"454","author":"S. J. Allen","year":"1988","unstructured":"Allen S. J., Dawbarn D., and Wilcock G. K. (1988) Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer\u2019s disease.Brain Res. 454, 275\u2013281.","journal-title":"Brain Res."},{"key":"BF03159935_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","volume":"43","author":"H. Arai","year":"1984","unstructured":"Arai H., Kosaka K., and Iizuka R. (1984a) Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer type dementia.J. Neurochem. 43, 388\u2013393.","journal-title":"J. Neurochem."},{"key":"BF03159935_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(84)90353-7","volume":"52","author":"H. Arai","year":"1984","unstructured":"Arai H., Moroji T., and Kosaka K. (1984b) Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer type dementia.Neurosci. Lett. 52, 73\u201378.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(85)90160-5","volume":"14","author":"A. Arendt","year":"1985","unstructured":"Arendt A., Bigl V., and Tennstedt A. (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical area in Alzheimer\u2019s disease.Neuroscience 14, 1\u201314.","journal-title":"Neuroscience"},{"key":"BF03159935_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00697388","volume":"61","author":"T. Arendt","year":"1983","unstructured":"Arendt T., Bigl V., Arendt A., and Tennstedt A. (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer\u2019s disease, paralysis agitans and Korsakoff\u2019s disease.Acta Neuropathol. (Berl.) 61, 101\u2013108.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00690530","volume":"75","author":"T. Arendt","year":"1988","unstructured":"Arendt T., Taubert G., Bigl V., and Arendt A. (1988) Amyloid deposition in the nucleus basalis of Meynert complex: A topographic marker for degenerating cell clusters in Alzheimer\u2019s disease.Acta Neuropathol. (Berl.) 75, 226\u2013232.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0306-4522(86)90141-7","volume":"19","author":"T. Arendt","year":"1986","unstructured":"Arendt T., Zveginsev H. G., and Leontovich T. A. (1986) Dendritic changes in the nucleus basalis of Menyert and in the diagonal band nucleus in Alzheimer\u2019s disease. A quantitative Golgi investigation.Neuroscience 19, 1265\u20131278.","journal-title":"Neuroscience"},{"key":"BF03159935_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0306-4522(89)90431-4","volume":"31","author":"D. M. Armstrong","year":"1989","unstructured":"Armstrong D. M., Benzing W. C., Evans J., Terry R. D., Shields D., and Hansen L. A. (1989) Substance P and somatostatin coexist within neuritic plaques: Implications for the pathogenesis of Alzheimer\u2019s disease.Neuroscience 31, 663\u2013671.","journal-title":"Neuroscience"},{"key":"BF03159935_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00005072-198901000-00007","volume":"48","author":"C. Bancher","year":"1989","unstructured":"Bancher C., Lassmann H., Budka H., Jellinger K., Grundke-Iqbal I., Iqbal K., Wiche G., Seitelberger F., and Wisniewski H. M. (1989) Antigenic profile of Lewy bodies: Immunocytochemical evidence for protein phosphorylation and ubiquitination.J. Neuropathol. Exp. Neurol. 48, 81\u201393.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410200502","volume":"20","author":"M. F. Beal","year":"1986","unstructured":"Beal M. F., and Martin J. B. (1986) Neuropeptides in neurological disease.Ann. Neurol. 20, 547\u2013565.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/syn.890020415","volume":"2","author":"M. F. Beal","year":"1988","unstructured":"Beal M. F., Clevens R. A., and Mazurek M. F. (1988) Somatostatin and neuropeptide Y immunoreactivity in Parkinson\u2019s disease dementia with Alzheimer\u2019s changes.Synapse 2, 463\u2013467.","journal-title":"Synapse"},{"key":"BF03159935_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.410200303","volume":"20","author":"M. F. Beal","year":"1986","unstructured":"Beal M. F., Mazurek F., Chattha G. K., Svedsen C. N., Bird E. D., and Martin J. B. (1986) Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer\u2019s disease.Ann. Neurol. 20, 282\u2013288.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.2861661","volume":"229","author":"M. F. Beal","year":"1985","unstructured":"Beal M. F., Mazurek M. F., and Tran V. T. (1985) Somatostatin receptors are reduced in cerebral cortex in Alzheimer\u2019s disease.Science 229, 289\u2013291.","journal-title":"Science"},{"key":"BF03159935_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0306-4522(87)90110-2","volume":"20","author":"R. M. Beckstead","year":"1987","unstructured":"Beckstead R. M. (1987) Striatal substance P cell clusters coincide with the high density terminal zones of the discontinuous nigrostriatal dopaminergic projection system in the cat.Neuroscience 20, 557\u2013576.","journal-title":"Neuroscience"},{"key":"BF03159935_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/brain\/103.1.23","volume":"103","author":"M. B. Bender","year":"1980","unstructured":"Bender M. B. (1980) Brain control of conjugate horizontal and vertical eye movements.Brain 103, 25\u201369.","journal-title":"Brain"},{"key":"BF03159935_CR23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H. Bernheimer","year":"1973","unstructured":"Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., and Seitelberger, F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical morphological and neurochemical correlations.J. Neurol. Sci. 20, 415\u2013455.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000212872","volume":"33","author":"V. Bigl","year":"1987","unstructured":"Bigl V., Arendt T., Fischer S., Werner M., and Arendt A. (1987) The cholinergic system in aging.Gerontology 33, 172\u2013180.","journal-title":"Gerontology"},{"key":"BF03159935_CR25","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-2262-4","volume-title":"Die Parkinson-Krankheit","author":"W. Birkmayer","year":"1985","unstructured":"Birkmayer W. and Riederer P. (1985)Die Parkinson-Krankheit 2nd Ed. (Springer, Wien).","edition":"2nd Ed."},{"issue":"(Suppl.) 2","key":"BF03159935_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000285133","volume":"19","author":"W. Birkmayer","year":"1986","unstructured":"Birkmayer W. and Riederer P. (1986) Biological aspects of depression in Parkinson\u2019s disease.Psychopathology 19 (Suppl.) 2, 58\u201361.","journal-title":"Psychopathology"},{"key":"BF03159935_CR27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ana.410170403","volume":"17","author":"G. Bissette","year":"1985","unstructured":"Bissette G., Nemeroff C. R., Decker M. W., Kizer J. S., Agid Y., and Javoy-Agid F. (1985) Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson\u2019s disease.Ann. Neurol. 17, 324\u2013328.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR28","first-page":"951","volume":"18","author":"B. Bogerts","year":"1983","unstructured":"Bogerts B., H\u00e4ntsch J., and Herzer M. (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.Biol. Psychiatry 18, 951\u2013969.","journal-title":"Biol. Psychiatry"},{"key":"BF03159935_CR29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.32.2.164","volume":"32","author":"W. Bondareff","year":"1982","unstructured":"Bondareff W., Mountjoy C. Q., and Roth M. (1982) Loss of neurons of origin of the adrenergic projections to the cerebral cortex (nucleus locus ceruleus) in senile dementia.Neurology 32, 164\u2013168.","journal-title":"Neurology"},{"key":"BF03159935_CR30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","volume":"1","author":"W. Bondareff","year":"1987","unstructured":"Bondareff W., Mountjoy C. Q., Roth M., Rossor M. N., Iversen L. L., Reynolds G. P. and Hauser D. L. (1987) Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease.Alzheimer Dis. Assoc. Disord. 1, 256\u2013262.","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BF03159935_CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1192\/bjp.157.3.327","volume":"157","author":"D. A. Bowen","year":"1990","unstructured":"Bowen D. A. (1990) Treatment of Alzheimer\u2019s disease.Br. J. Psychiatry 157, 327\u2013330.","journal-title":"Br. J. Psychiatry"},{"key":"BF03159935_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244987","volume":"76","author":"W. J. Brooks","year":"1989","unstructured":"Brooks W. J., Jarvis M. F., and Wagner C. (1989) Astrocytes as a primary locus for the conversion of MPTP into MPP+.J. Neural Transm. 76, 1\u201312.","journal-title":"J. Neural Transm."},{"key":"BF03159935_CR33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.410240409","volume":"24","author":"W. J. Burke","year":"1988","unstructured":"Burke W. J., Chung H. D., Huang J. S., Grossberg G. T. and Joh T. H. (1988) Evidence for retrograde degeneration of epinephrine neurons in Alzheimer\u2019s disease.Ann. Neurol. 24, 532\u2013536.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-510X(83)90045-X","volume":"54","author":"J. M. Candy","year":"1983","unstructured":"Candy J. M., Perry R. H., Perry E. K., Irving D., Blessed G., Fairbairn A. F., and Tomlinson, B. E. (1983) Pathological changes in the nucleus basalis of Meynert in Alzheimer\u2019s and Parkinson\u2019s disease.J. Neurol. Sci. 54, 277\u2013289.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-510X(85)90070-X","volume":"71","author":"J. M. Candy","year":"1985","unstructured":"Candy J. M., Gascoigne A. D., Biggins A., Smith I., Perry R. H., Perry E. K., McDermott J. R., and Edwardson J. E. (1985) Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer\u2019s disease.J. Neurol. Sci. 71, 315\u2013323.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR36","first-page":"254","volume":"319","author":"S. W. Carmichael","year":"1988","unstructured":"Carmichael S. W., Wilson R. J., Brimijoin W. S., Melton L. J., Okazaki J., Yaksh T., Ahlskog J. E., Stoddard S. L., and Tyce G. M. (1988) Decreased catecholamines in the adrenal medulla of patients with parkinsonism.New Engl. J. Med. 319, 254.","journal-title":"New Engl. J. Med."},{"key":"BF03159935_CR37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.37.1.42","volume":"37","author":"R. Cash","year":"1987","unstructured":"Cash R., Dennis R., L\u2019Heureux R., Raisman R., Javoy-Agid F., and Scatton B. (1987) Parkinson\u2019s disease and dementia: Norepinephrine and dopamine in locus ceruleus.Neurology 37, 42\u201346.","journal-title":"Neurology"},{"key":"BF03159935_CR38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cne.902600205","volume":"260","author":"V. Chan-Palay","year":"1987","unstructured":"Chan-Palay V. (1987) Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold\/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.J. Comp. Neurol. 260, 201\u2013223.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/cne.902380403","volume":"238","author":"V. Chan-Palay","year":"1985","unstructured":"Chan-Palay V., Allen Y. S., Lang W., Haesler U., and Polak J. M. (1985) Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer\u2019s type dementia.J. Comp. Neurol 238, 382\u2013390.","journal-title":"J. Comp. Neurol"},{"key":"BF03159935_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.902870307","volume":"287","author":"V. Chan-Palay","year":"1989","unstructured":"Chan-Palay V. and Asan E. (1989a) Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression.J. Comp. Neurol. 287, 357\u2013372.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","volume":"287","author":"V. Chan-Palay","year":"1989","unstructured":"Chan-Palay V. and Asan E. (1989b) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression.J. Comp. Neurol. 287, 373\u2013392.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cne.902480306","volume":"248","author":"V. Chan-Palay","year":"1986","unstructured":"Chan-Palay V., K\u00f6hler C., Haesler U., Lang W., and Yasargil G. (1986) Distribution of altered hippocampal neurons and axons immunoreactive with antisera against Neuropeptide Y in Alzheimer\u2019s type dementia.J. Comp. Neurol. 248, 360\u2013375.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR43","first-page":"513","volume-title":"The hippocampus\u2014New vistas","author":"V. Chan-Palay","year":"1989","unstructured":"Chan-Palay V., K\u00f6hler C., and H\u00f6chli M. (1989) Coexistence of somatostatin and neuropeptide Y in the hippocampus of patients with Alzheimer\u2019s and Parkinson\u2019s disease,The hippocampus\u2014New vistas pp. 513\u2013534, A. R. Liss, New York."},{"key":"BF03159935_CR44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0306-4522(90)90273-7","volume":"19","author":"G. Chinaglia","year":"1990","unstructured":"Chinaglia G., Probst A., and Palacios J. M. (1990) Neurotensin receptors in Parkinson\u2019s disease and progressive supranuclear palsy: An autoradiographic study in basal ganglia.Neuroscience 19, 351\u2013360.","journal-title":"Neuroscience"},{"key":"BF03159935_CR45","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.1986.00520100013007","volume":"43","author":"H. C. Chui","year":"1986","unstructured":"Chui H. C., Mortimer J. A., Slager U., Barrow C., Bonareff W., and Webster D. D. (1986) Pathological correlates of dementia in Parkinson\u2019s disease.Arch. Neurol. 43, 991\u2013995.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4522(89)90239-X","volume":"28","author":"S. K. Coles","year":"1989","unstructured":"Coles S. K., Iles J. F., and Nicolopoulos-Stournaras S. (1989) The mesencephalic centre controlling locomotion in the rat.Neuroscience 28, 149\u2013157.","journal-title":"Neuroscience"},{"key":"BF03159935_CR47","first-page":"102","volume":"55","author":"J. Constantinidis","year":"1988","unstructured":"Constantinidis J., Bouras C., and Vallet P. G. (1988) Neuropeptides in Alzheimer\u2019s and in Parkinson\u2019s disease.Mt. Sinai J. Med. 55, 102\u2013115.","journal-title":"Mt. Sinai J. Med."},{"key":"BF03159935_CR48","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1471-4159.1984.tb06081.x","volume":"43","author":"A. J. Cross","year":"1984","unstructured":"Cross A. J., Crow T. J., Ferier I. N., Johnson A. J., Bloom S. R. and Corsellis J. A. N. (1984) Serotonin receptor changes in dementia of the Alzheimer type.J. Neurochem. 43, 1574\u20131581.","journal-title":"J. Neurochem."},{"key":"BF03159935_CR49","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0028-3908(84)90100-X","volume":"23","author":"T. J. Crow","year":"1984","unstructured":"Crow T. J., Cross A. J., Cooper S. J., Deakin J. F., Ferrier I. N., Johnson J. A., Joseph M. H., Owen F., Poulter M., and Lofthouse R. (1984) Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.Neuropharmacology 23, 1561\u20131569.","journal-title":"Neuropharmacology"},{"key":"BF03159935_CR50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00005072-198407000-00001","volume":"43","author":"C. A. Curcio","year":"1984","unstructured":"Curcio C. A. and Kemper T. (1984) Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density.J. Neuropathol. Exp. Neurol. 43, 359\u2013368.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.410220207","volume":"22","author":"R. J. D\u2019Amato","year":"1987","unstructured":"D\u2019Amato R. J., Zweig R. M., Whitehouse P. J., Wenk G. L., Singer H. S., Mayeux R., Price D. L., and Snyder S. H. (1987) Aminergic systems in Alzheimer\u2019s disease and Parkinson\u2019s disease.Ann. Neurol. 22, 229\u2013236.","journal-title":"Ann. Neurol."},{"issue":"Suppl.","key":"BF03159935_CR52","first-page":"23","volume":"49","author":"P. Davies","year":"1988","unstructured":"Davies P. (1988) Neurochemical studies: An update on Alzheimer\u2019s disease.J. Clin. Psychiatry 49 (Suppl.), 23\u201328.","journal-title":"J. Clin. Psychiatry"},{"key":"BF03159935_CR53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/288279a0","volume":"288","author":"P. Davies","year":"1980","unstructured":"Davies P., Katzman R., and Terry R. D. (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease.Nature 288, 279.","journal-title":"Nature"},{"key":"BF03159935_CR54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"G. C. Davis","year":"1979","unstructured":"Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Reichert C. M., and Kopin I. J. (1979) Parkinsonism secondary to intravenous injection of meperidine analogues.Psychiatr. Res. 1, 249\u2013254.","journal-title":"Psychiatr. Res."},{"key":"BF03159935_CR55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0304-3940(86)90455-6","volume":"70","author":"D. Dawbarn","year":"1986","unstructured":"Dawbarn D., Rossor M. N., Mountjoy C. Q., Roth M., and Emson P. C. (1986) Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in dementia of Alzheimer type.Neurosci. Lett. 70, 154\u2013159.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF00691284","volume":"78","author":"D. W. Dickson","year":"1989","unstructured":"Dickson D. W., Crystal H., Mattiace L. A. (1989) Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques.Acta Neuropathol. (Berl.) 78, 572\u2013584.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890010205","volume":"1","author":"M. M. Dietl","year":"1987","unstructured":"Dietl M. M., Probst A., and Palacios J. M. (1987) On the distribution of cholecystokinin receptor binding sites in the human brain. An autoradiographic study.Synapse 1, 169\u2013183.","journal-title":"Synapse"},{"key":"BF03159935_CR58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0317167100037070","volume":"13","author":"R. Doucette","year":"1986","unstructured":"Doucette R., Fisman M., Hachinski V. C., and Mersky H. (1986) Cell loss from the nucleus basalis of Meynert in Alzheimer disease.Can. J. Neurol. Sci. 13, 435\u2013440.","journal-title":"Can. J. Neurol. Sci."},{"key":"BF03159935_CR59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410280202","volume":"28","author":"B. Dubois","year":"1990","unstructured":"Dubois B., Pillon B., Lhermitte F., and Agid Y. (1990) Cholinergic deficiency and frontal dysfunction in Parkinson\u2019s disease.Ann. Neurol. 28, 117\u2013121.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR60","first-page":"184","volume":"141","author":"B. Dubois","year":"1985","unstructured":"Dubois B., Hauw J. J., Ruberg M., Serdaru M., Javoy-Agid F., and Agid Y. (1985) D\u00e9mence et maladie de Parkinson: Correlations biochimiques et anatomo-cliniquesRev. Neurol. (Paris) 141, 184\u2013193.","journal-title":"Rev. Neurol. (Paris)"},{"key":"BF03159935_CR61","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/brain\/86.4.781","volume":"86","author":"M. J. Eadie","year":"1963","unstructured":"Eadie M. J. (1963) The pathology of certain medullary nuclei in parkinsonism.Brain 86, 781\u2013795.","journal-title":"Brain"},{"key":"BF03159935_CR62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0301-0082(86)90012-2","volume":"27","author":"J. Epelbaum","year":"1983","unstructured":"Epelbaum J. (1983) Somatostatin in the central nervous system: Physiology and pathological modifications.Progr. Neurobiol. 27, 63\u2013100.","journal-title":"Progr. Neurobiol."},{"key":"BF03159935_CR63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-510X(88)90242-0","volume":"87","author":"J. Epelbaum","year":"1988","unstructured":"Epelbaum J., Javoy-Agid F., Enjalbert A., Krantic S., Kordon C., and Agid Y. (1988) Somatostatin concentrations and binding sites in human frontal cortex are differently affected in Parkinson\u2019s disease associated with dementia and supranuclear palsy.J. Neurol. Sci. 87, 167\u2013174.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0006-8993(83)90277-9","volume":"278","author":"J. Epelbaum","year":"1983","unstructured":"Epelbaum J., Ruberg M., Moyse E, Javoy-Agid F., Dubois B., and Agid Y. (1983) Somatostatin and dementia in Parkinson\u2019s disease.Brain Res. 278, 376\u2013397.","journal-title":"Brain Res."},{"key":"BF03159935_CR65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/jnnp.53.2.161","volume":"53","author":"M. M. Esiri","year":"1990","unstructured":"Esiri M. M., Pearson R. C. A., Steele J. E., Bowen D. M., and Powell T. P. S. (1990) A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer\u2019s disease.J. Neurol. Neurosurg. Psychiatry 53, 161\u2013165.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR66","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0306-4522(86)90142-9","volume":"19","author":"P. Etienne","year":"1986","unstructured":"Etienne P., Robitaille Y., Wood P., Gauthier S., Nair N. P. V., and Quirion R. (1986) Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer\u2019s disease.Neuroscience 19, 1279\u20131291.","journal-title":"Neuroscience"},{"key":"BF03159935_CR67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S0317167100035721","volume":"13","author":"C. Ezrin-Waters","year":"1986","unstructured":"Ezrin-Waters C. and Resch L. (1986) The nucleus basalis of Meynert.Can. J. Neurol. Sci. 13, 8\u201314.","journal-title":"Can. J. Neurol. Sci."},{"key":"BF03159935_CR68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0306-4530(90)90017-4","volume":"15","author":"I. N. Ferrier","year":"1990","unstructured":"Ferrier I. N. and Leake A. (1990) Peptides in the neocortex in Alzheimer\u2019s disease and aging.Psychoneuroendocrinology 15, 89\u201396.","journal-title":"Psychoneuroendocrinology"},{"key":"BF03159935_CR69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","volume":"63","author":"S. L. Foote","year":"1983","unstructured":"Foote S. L., Bloom F. E., and Aston-Jones G. (1983) Nucleus locus ceruleus: New evidence of anatomical and physiological specificity.Physiol. Rev. 63, 844\u2013914.","journal-title":"Physiol. Rev."},{"key":"BF03159935_CR70","first-page":"35","volume":"45","author":"L. S. Forno","year":"1986","unstructured":"Forno L. S. (1986) The Lewy body in Parkinson\u2019s disease.Adv. Neurol. 45, 35\u201343.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR71","unstructured":"Forno L. S. (1990) Neuropathology of MPTP-induced parkinsonism in animals,Abstr., XIth International Congress of Neuropathology, Kyoto, Sept. 2\u20138, 1990, p. 5."},{"key":"BF03159935_CR72","first-page":"123","volume":"23","author":"L. S. Forno","year":"1979","unstructured":"Forno L. S. and Norville R. L. (1979) Ultrastructure of the neostriatum in Huntington\u2019s and Parkinson\u2019s disease.Adv. Neurol. 23, 123\u2013135.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00005072-198505000-00066","volume":"44","author":"L. S. Forno","year":"1985","unstructured":"Forno L. S., Gardiner R. E., and Eng L. F. (1985) Somatostatin-like immunoreactivity in the human basal ganglia (abstract).J. Neuropathol. Exp. Neurol. 44, 326.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-8993(88)91111-0","volume":"448","author":"L. S. Forno","year":"1988","unstructured":"Forno L. S., Langston J. W., DeLanney L. E., and Irwin I. (1988) An electron microscopic study of MPTP-induced inclusion bodies in old monkey.Brain Res. 448, 150.","journal-title":"Brain Res."},{"key":"BF03159935_CR75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.410200403","volume":"20","author":"L. S. Forno","year":"1986","unstructured":"Forno L. S., Langston J. W., DeLanney L. E., Irwin I., and Ricaurte G. A. (1986) Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.Ann. Neurol. 20, 449\u2013455.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(86)90015-7","volume":"63","author":"N. L. Foster","year":"1986","unstructured":"Foster N. L., Tamminaga C. A., O\u2019Donohue T. L., Tanimoto K., Bird E. D., and Chase T. N. (1986) Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer\u2019s disease.Neurosci. Lett. 63, 71\u201375.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR77","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1017\/S031716710002984X","volume":"16","author":"P. T. Francis","year":"1989","unstructured":"Francis P. T. and Bowen D. M. (1989) Tacrine, a drug with therapeutic potential for dementia: Postmortem biochemical evidence.Can. J. Neurol. Sci. 16, 504\u2013510.","journal-title":"Can. J. Neurol. Sci."},{"key":"BF03159935_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(87)90073-6","volume":"78","author":"P. T. Francis","year":"1987","unstructured":"Francis P. T., Bowen D. M., Lowe S. L., Neary D., Mann D. M. A., and Snowden J. S. (1987) Somatostatin content and release measured in cerebral biopsies from demented patients.J. Neurol. Sci. 78, 1\u201316.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00695605","volume":"64","author":"P. Gaspar","year":"1984","unstructured":"Gaspar P. and Gray F. (1984) Dementia in idiopathic Parkinson\u2019s disease. A neuropathological study of 32 cases.Acta Neuropathol. (Berl.) 64, 43\u201352.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0306-4522(87)90197-7","volume":"22","author":"P. Gaspar","year":"1987","unstructured":"Gaspar P., Berger B., and Lesur A. (1987) Somatostatin 28 and neuropeptide Y innervation in the septal area and related cortical and subcortical structures of the human brain. Distribution, relationship and evidence for different coexistence.Neuroscience 22, 49\u201373.","journal-title":"Neuroscience"},{"key":"BF03159935_CR81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","volume":"24","author":"D. C. German","year":"1988","unstructured":"German D. C., Dubsch M., Askari S., Speciale S. G., and Bowden D. M. (1988a) 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine-induced parkinsonian syndrome, in Macaca fascicularis: Which midbrain dopaminergic neurons are lost?Neuroscience 24, 161\u2013174.","journal-title":"Neuroscience"},{"key":"BF03159935_CR82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410260403","volume":"26","author":"D. C. German","year":"1989","unstructured":"German D. C., Manaye K., Smith W. K., Woodward D. J., and Saper C. B. (1989) Midbrain catecholaminergic loss in Parkinson\u2019s disease: Computer visualization.Ann. Neurol. 26, 507\u2013514.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR83","unstructured":"German D. C., Manaye K., Smith W. K., White C. L., Woodward D. J., and Mann D. M. A. (1990) Catecholaminergic cell loss in Parkinson\u2019s disease: Computer image,Abstr., XIth International Congress of Neuropathology, Kyoto, Sept. 2\u20138, 1990, p. 76."},{"key":"BF03159935_CR84","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1523\/JNEUROSCI.08-05-01776.1988","volume":"8","author":"D. C. German","year":"1988","unstructured":"German D. C., Walker B. S., Manaye K., Smith W. K., Woodward D. J., and North A. J. (1988b) The human locus coeruleus: Computer reconstruction of cellular distribution.J. Neurosci. 8, 1776\u20131788.","journal-title":"J. Neurosci."},{"key":"BF03159935_CR85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0306-4522(87)90123-0","volume":"21","author":"D. C. German","year":"1987","unstructured":"German D. C., White C. L. III, and Sparkman D. R. (1987) Alzheimer\u2019s disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex.Neuroscience 21, 305\u2013312.","journal-title":"Neuroscience"},{"key":"BF03159935_CR86","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0304-3940(87)90720-8","volume":"76","author":"H. J. Gertz","year":"1987","unstructured":"Gertz H. J., Cervos-Navarro J., and Ewald V. (1987) The septo-hippocampal pathway in patients suffering from dementia of Alzheimer\u2019s type. Evidence for neuronal plasticity?Neurosci. Lett. 76, 228\u2013232.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR87","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0306-4522(89)90399-0","volume":"33","author":"C. Geula","year":"1989","unstructured":"Geula C. and Mesulam M. M. (1989) Cortical cholinergic fibers in aging and Alzheimer\u2019s disease: A morphometric study.Neuroscience 33, 469\u2013481.","journal-title":"Neuroscience"},{"key":"BF03159935_CR88","unstructured":"Gibb W. R. G. (1990) Juvenile parkinsonism, dopa-responsive dystonia and nigrostriatal subdivision,Abstr. XIth International Congress Neuropathology, Kyoto, Sept 2\u20138, 1990, p. 5."},{"key":"BF03159935_CR89","first-page":"31","volume":"53","author":"W. R. G. Gibb","year":"1990","unstructured":"Gibb W. R. G., Fearnley J. M., and Lees A. J. (1990) The anatomy and pigmentation of the human substania nigra in relation to selective neuronal vulnerability.Adv. Neurol. 53, 31\u201334.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.52.2.193","volume":"52","author":"W. R. G. Gibb","year":"1989","unstructured":"Gibb W. R. G., Mountjoy C. Q., Mann D. M. A., and Lees A. J. (1989a) The substantia nigra and ventral tegmental areas in Alzheimer\u2019s disease and Down\u2019s syndrome.J. Neurol. Neurosurg. Psychiatry 52, 193\u2013200.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mds.870040109","volume":"4","author":"W. R. G. Gibb","year":"1989","unstructured":"Gibb W. R. G., Terruli M., Lees A. J., Jenner P., and Marsden C. D. (1989b) The evolution of morphological changes in the nervous system of the common marmoset following the acute administration of MPTP.Movement Disord. 4, 53\u201374.","journal-title":"Movement Disord."},{"key":"BF03159935_CR92","first-page":"51","volume-title":"Neural Peptides and Neuronal Communication","author":"J. Glowinski","year":"1980","unstructured":"Glowinski J., Michelot R., and Cheramy A. (1980) Role of striatonigral substance P in the regulation of activity of the striatonigral dopaminergic neurones.Neural Peptides and Neuronal Communication (Costa E. and Trabuchi M., eds.), pp. 51\u201363, Raven, New York."},{"key":"BF03159935_CR93","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.410260613","volume":"26","author":"S. Goto","year":"1989","unstructured":"Goto S., Hirano A., and Matsumoto S. (1989) Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson\u2019s disease and striatonigral degeneration.Ann. Neurol. 26, 766\u2013770.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR94","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.410270511","volume":"27","author":"S. Goto","year":"1990","unstructured":"Goto S., Hirano A., and Matsumoto S. (1990) Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson\u2019s and Alzheimer\u2019s diseases.Ann. Neurol. 27, 520\u2013527.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR95","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0197-4580(90)90114-F","volume":"11","author":"E. Goudsmit","year":"1990","unstructured":"Goudsmit E., Hofman M. A., Fliers E., and Swaab D. F. (1990) The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, and Alzheimer\u2019s disease.Neurobiol. Aging 11, 529\u2013536.","journal-title":"Neurobiol. Aging"},{"key":"BF03159935_CR96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005072-198501000-00004","volume":"44","author":"M. R. Grafe","year":"1985","unstructured":"Grafe M. R., Forno L. S., and Eng L. F. (1985) Substance P and met-enkephalin immunoreactivity in Parkinson\u2019s, Huntington\u2019s and Alzheimer\u2019s disease.J Neuropathol. Exp. Neurol. 44, 47\u201359.","journal-title":"J Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR97","first-page":"135","volume-title":"Neuropeptides in Neurologic and Psychiatric Disease","author":"A. M. Graybiel","year":"1986","unstructured":"Graybiel A. M. (1986) Neuropeptides in the basal ganglia,Neuropeptides in Neurologic and Psychiatric Disease (Martin J. B. and Barchas J. eds.), pp. 135\u2013161, Raven, New York."},{"key":"BF03159935_CR98","volume-title":"Neural mechanisms in disorders of movement","author":"A. M. Graybiel","year":"1989","unstructured":"Graybiel A. M. (1989) Dopaminergic and cholinergic systems in the striatum.Neural mechanisms in disorders of movement (Crossman A. and Sambrook M. A., eds.), Libbey, London."},{"key":"BF03159935_CR99","first-page":"17","volume":"53","author":"A. M. Graybiel","year":"1990","unstructured":"Graybiel, A. M., Hirsch E. C., and Agid Y. (1990) The nigrostriatal system in Parkinson\u2019s disease.Adv. Neurol. 53, 17\u201329.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR100","first-page":"352","volume":"43","author":"R. J. Guiloff","year":"1980","unstructured":"Guiloff, R. J., George R. J. and Marsden D. C. (1980) Reversible supranuclear ophthalmoplegia associated with parkinsonism.J. Neurol. Neurosurg. Psychiatry 43, 352\u2013354.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR101","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"G. M. Halliday","year":"1990","unstructured":"Halliday G. M., Blumbergs P. C., Cotton R. G. H., Blessing W. W., and Geffen L. B. (1990a) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease.Brain Res. 510, 104\u2013107.","journal-title":"Brain Res."},{"key":"BF03159935_CR102","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","volume":"27","author":"G. M. Halliday","year":"1990","unstructured":"Halliday G. M., Blumbergs P. C., Cotton R. G. H., Howe P. R. C., Blessing W. W., and Geffen L. B. (1990b) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease.Ann. Neurol. 27, 373\u2013385.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR103","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(90)90223-Q","volume":"39","author":"G. M. Halliday","year":"1990","unstructured":"Halliday G. M., Gai, W. P., Blessing W. W., and Geffen L. B. (1990c) Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain.Neuroscience 39, 81\u201396.","journal-title":"Neuroscience"},{"key":"BF03159935_CR104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cne.902620109","volume":"262","author":"A. E. Hallanger","year":"1987","unstructured":"Hallanger A. E., Levey A. L., Lee H. J., Rye D. B., and Wainer B. H. (1987) The origins of cholinergic and other subcortical afferents to the thalamus in the rat.J. Comp. Neurol. 262, 105\u2013124.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR105","first-page":"387","volume":"48","author":"R. Hassler","year":"1938","unstructured":"Hassler R. (1938) Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus.J. Psychol. Neurol. (Lpz.) 48, 387\u2013476.","journal-title":"J. Psychol. Neurol. (Lpz.)"},{"key":"BF03159935_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-198401000-00001","volume":"31","author":"J. C. Hedreen","year":"1984","unstructured":"Hedreen J. C., Struble R. G., Whitehouse P. J., and Price D. L. (1984) Topography of the magnocellular basal forebrain system in human brain.J. Neuropathol. Exp. Neurol. 31, 1\u201321.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR107","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.35.5.762","volume":"35","author":"C. W. Heilig","year":"1985","unstructured":"Heilig C. W., Knopman D. S., Mastri A. R., and Frey W. (1985) Dementia without Alzheimer pathology.Neurology 35, 762\u2013765.","journal-title":"Neurology"},{"key":"BF03159935_CR108","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0165-0173(89)90017-9","volume":"14","author":"L. Hertz","year":"1989","unstructured":"Hertz L. (1989) Is Alzheimer\u2019s disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells?Brain Res. Rev. 14, 335\u2013353.","journal-title":"Brain Res. Rev."},{"key":"BF03159935_CR109","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E. C. Hirsch","year":"1988","unstructured":"Hirsch E. C., Graybiel A. M., and Agid Y. A. (1988) Melanized dopaminergic neurons are differently susceptible to degeneration in Parkinson\u2019s disease.Nature 334, 345\u2013348.","journal-title":"Nature"},{"key":"BF03159935_CR110","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","volume":"84","author":"E. C. Hirsch","year":"1987","unstructured":"Hirsch E. C., Graybiel A. M., Duyckaerts C., and Javoy-Agid F. (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson\u2019s disease and progressive supranuclear palsy.Proc. Nat. Acad. Sci. USA 84, 5976\u20135980.","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"BF03159935_CR111","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF01945354","volume":"43","author":"T. H\u00f6kfelt","year":"1987","unstructured":"H\u00f6kfelt T., Millhorn D., Seroogy K., Tsuruo Y., Ceccatelli S., Lindh B., Meister B., Melander T., Schalling M., Bartfai T., and Terenius L. (1987) Coexistence of peptides with classical neurotransmitters.Experientia 43, 768\u2013780.","journal-title":"Experientia"},{"key":"BF03159935_CR112","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0006-2952(75)90190-2","volume":"24","author":"O. Hornykiewicz","year":"1975","unstructured":"Hornykiewicz O. (1975) Parkinson\u2019s disease and its chemotherapy.Biochem. Pharmacol. 24, 1061\u20131065.","journal-title":"Biochem. Pharmacol."},{"key":"BF03159935_CR113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-642-73899-9_6","volume-title":"Drugs for the Treatment of Parkinson\u2019s Disease","author":"O. Hornykiewicz","year":"1989","unstructured":"Hornykiewicz O. (1989) The neurochemical basis of the pharmacology of Parkinson\u2019s disease,Drugs for the Treatment of Parkinson\u2019s Disease (Calne D. B., ed.),Handbook of Experimental Pharmacology vol. 88, pp. 185\u2013204, Springer, Berlin."},{"key":"BF03159935_CR114","first-page":"57","volume-title":"Parkinsonism and Aging","author":"O. Hornykiewicz","year":"1989","unstructured":"Hornykiewicz O., Pifl C., Kish S. J., Shannak K., and Schingnitz G. (1989) Biochemical changes in idiopathic, Parkinson\u2019s disease, aging, and MPTP parkinsonism: Similarities and differences,Parkinsonism and Aging (Calne, D. B., et al., eds.), pp. 57\u201367, Raven, New York."},{"key":"BF03159935_CR115","first-page":"326","volume":"68","author":"S. Hunter","year":"1985","unstructured":"Hunter S. (1985) The rostral mesencephalon in Parkinson\u2019s and Alzheimer\u2019s disease.Acta Neuropathol. (Berl.) 68, 326\u2013334.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR116","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00691428","volume":"70","author":"Y. Ichimija","year":"1986","unstructured":"Ichimija Y., Arai H., Kosaka K., and Iizuka R. (1986) Morphological and biochemical changes in the cholinergic and monoaminergic system in Alzheimer-type dementia.Acta Neuropathol. (Berl.) 70, 112\u2013116.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR117","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cne.902430307","volume":"243","author":"H. Imai","year":"1987","unstructured":"Imai H., Steindler D. A., and Kitai S. (1987) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat.J. Comp. Neurol. 243, 363.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR118","first-page":"435","volume-title":"Alzheimer\u2019s Disease: Advances in Basic Research and Therapy","author":"V. M. Ingram","year":"1987","unstructured":"Ingram V. M., Koenig J. H., Miller C. H., Moore H. E., Blanchard B., and Perry D. E. (1987) The locus coeruleus: Computer assisted 3-dimensional analysis of degeneration in Alzheimer\u2019s and Down\u2019s disease,Alzheimer\u2019s Disease: Advances in Basic Research and Therapy (Wurtman R. J., Corkin, S. H., and Growden J. H. eds.), Center for Brain Science and Metabolism Charitable Trust, Cambridge, pp. 435\u2013440."},{"key":"BF03159935_CR119","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(90)90389-L","volume":"38","author":"F. Javoy-Agid","year":"1990","unstructured":"Javoy-Agid F., Hirsch E. C., Dumas S., Duyckaerts C., Mallet J., and Agid Y. (1990) Decreased tysosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson\u2019s disease: An in situ hybridization study.Neuroscience 38, 245\u2013253.","journal-title":"Neuroscience"},{"key":"BF03159935_CR120","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1471-4159.1981.tb04672.x","volume":"37","author":"F. Javoy-Agid","year":"1981","unstructured":"Javoy-Agid F., Ploska A., and Agid Y. (1981) Microtopography of tyrosine hydroxylase, glutamic adic decarboxylase and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and parkinsonian brain.J. Neurochem. 37, 1218\u20131227.","journal-title":"J. Neurochem."},{"key":"BF03159935_CR121","first-page":"189","volume":"40","author":"F. Javoy-Agid","year":"1984","unstructured":"Javoy-Agid F., Ruberg M., Taquer H., Bobobza B., and Agid Y. (1984) Biochemical neuropathology of Parkinson\u2019s disease.Adv. Neurol. 40, 189\u2013197.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR122","first-page":"1","volume":"45","author":"K. Jellinger","year":"1986","unstructured":"Jellinger K. (1986) Overview of morphological changes in Parkinson\u2019s disease.Adv. Neurol. 45, 1\u201318.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR123","first-page":"124","volume-title":"Movement Disorders 2","author":"K. Jellinger","year":"1987","unstructured":"Jellinger K. (1987) The pathology of parkinsonism,Movement Disorders 2 (Marsden C. D. and Fahn St., eds.), pp. 124\u2013165, Butterworth, London."},{"key":"BF03159935_CR124","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp.51.4.540","volume":"51","author":"K. Jellinger","year":"1988","unstructured":"Jellinger K. (1988) The pedunculopontine nucleus in Parkinson\u2019s disease, supranuclear palsy and Alzheimer\u2019s disease.J. Neurol. Neurosurg. Psychiatry 51, 540\u2013544.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-642-73899-9_2","volume-title":"Drugs for the Treatment of Pakinson\u2019s Disease","author":"K. Jellinger","year":"1989","unstructured":"Jellinger K. (1989) Pathology of Parkinson\u2019s syndrome,Drugs for the Treatment of Pakinson\u2019s Disease (Calne, D. B., ed.), pp. 47\u2013112, Springer, Berlin."},{"key":"BF03159935_CR126","first-page":"69","volume-title":"Function and Dysfunction of the Basal Ganglia","author":"K. Jellinger","year":"1990","unstructured":"Jellinger K. (1990a) Changes in subcortical nuclei in Parkinson\u2019s disease,Function and Dysfunction of the Basal Ganglia (Franks A. J., Ironside J. W., et al., eds.), pp. 69\u201394, Manchester University Press, Manchester, NY."},{"key":"BF03159935_CR127","first-page":"1","volume":"53","author":"K. Jellinger","year":"1990","unstructured":"Jellinger K. (1990b) New developments in the pathology of Parkinson\u2019s diseaseAdv. Neurol. 53, 1\u201316.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR128","first-page":"67","volume-title":"Alzheimer\u2019s Disease: Epidemiology, Neurochemistry and Clinics","author":"K. Jellinger","year":"1990","unstructured":"Jellinger K. (1990c) Morphology of Alzheimer\u2019s disease and related disorders,Alzheimer\u2019s Disease: Epidemiology, Neurochemistry and Clinics (Beckmann H., Maurer M., Riederer P., eds.),Key Topics in Brain Research, pp. 67\u201377, Springer, Wien."},{"key":"BF03159935_CR129","first-page":"3","volume-title":"Parkinson-Krankheit und Nigraproze\u00df","author":"K. Jellinger","year":"1990","unstructured":"Jellinger K. and Paulus W. (1990) Bedeutung der Nigraver\u00e4nderungen bei Parkinson-Syndromen,Parkinson-Krankheit und Nigraproze\u00df, (Fischer, P.-A., ed.), pp. 3\u201327 Basle: Ed. Roche."},{"key":"BF03159935_CR130","first-page":"140","volume-title":"Function and Dysfunction of the Basal Ganglia","author":"P. Jenner","year":"1990","unstructured":"Jenner P. and Marsden C. D. (1990) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): An update on its relevance to the cause and treatment of Parkinson\u2019s disease,Function and Dysfunction of the Basal Ganglia (Franks A. J., et al., eds.), pp. 140\u2013160, Manchester University Press, Manchester, NY."},{"key":"BF03159935_CR131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1212\/WNL.41.1.25","volume":"41","author":"J. L. Juncos","year":"1991","unstructured":"Juncos J. L., Hirsch E. C., Malessa S., Duyckaerts C., Hersh L. B., and Agid Y. (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy.Neurology 41, 25\u201330.","journal-title":"Neurology"},{"key":"BF03159935_CR132","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ana.410230206","volume":"23","author":"R. Katzman","year":"1988","unstructured":"Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X., and Peck A. (1988) Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous cortical plaques.Ann. Neurol. 23, 138\u2013144.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR133","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0006-8993(89)90657-4","volume":"501","author":"M. Kelly","year":"1989","unstructured":"Kelly M. and Kowall N. (1989) Corticotropin-releasing factor immunoreactive neurons persist throughout the brain in Alzheimer\u2019s disease.Brain Res. 501, 392.","journal-title":"Brain Res."},{"key":"BF03159935_CR134","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"S. J. Kish","year":"1988","unstructured":"Kish S. J., Shannak K., and Hornykiewicz O. (1988) Uneven patterns of dopamine loss in the striatum of patients with Parkinson\u2019s disease.N. Engl. J. Med. 318, 876\u2013880.","journal-title":"N. Engl. J. Med."},{"key":"BF03159935_CR135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(87)90551-9","volume":"78","author":"C. K\u00f6hler","year":"1987","unstructured":"K\u00f6hler C., Erikson L. G., Davies S., and Chan-Palay V. (1987) Colocalization of neuropeptide tyrosine and somatostatin immunoreactivity in neurons of individual hippocampal subfields in rat.Neurosci. Lett. 78, 1\u20136.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR136","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0306-4522(88)90099-1","volume":"26","author":"C. Konradi","year":"1988","unstructured":"Konradi C., Svoma E., Jellinger K., Riederer P., Denney R. M. (1988) Topographic immunocytochemical mapping of monoamine oxidase A, monoamine oxidase B and tyrosine hydroxylase in human postmortem brain stem.Neuroscience 26, 791\u2013802.","journal-title":"Neuroscience"},{"key":"BF03159935_CR137","first-page":"43","volume":"55","author":"I. J. Kopin","year":"1988","unstructured":"Kopin I. J. and Schoenberg D. G. (1988) MPTP in animal models of Parkinson\u2019s disease.Mt. Sinai Med. J. 55, 43\u201349.","journal-title":"Mt. Sinai Med. J."},{"key":"BF03159935_CR138","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-7091-8994-8_5","volume-title":"Early Diagnosis and Preventive Therapy in Parkinson Disease","author":"A. D. Korczyn","year":"1989","unstructured":"Korczyn A. D. (1989) Autonomic nervous system screening in patients with early Parkinson\u2019s disease,Early Diagnosis and Preventive Therapy in Parkinson Disease (Przuntek H. and Riederer P., eds.), pp. 41\u201348, Springer, Wien-New York."},{"key":"BF03159935_CR139","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410230202","volume":"23","author":"N. W. Kowall","year":"1988","unstructured":"Kowall N. W., and Beal M. F. (1988) Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in Alzheimer\u2019s disease.Ann. Neurol. 23, 105\u2013114.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(86)90969-8","volume":"375","author":"Y. Kubota","year":"1986","unstructured":"Kubota Y., Inagaki S., and Kito S. (1986) Innervation of substance P neurons by catecholaminergic terminals in the neostriatum.Brain Res. 375, 163\u2013167.","journal-title":"Brain Res."},{"key":"BF03159935_CR141","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-73899-9_7","volume-title":"Drugs for the treatment of Parkinson\u2019s Disease","author":"J. W. Langston","year":"1989","unstructured":"Langston J. W. and Irwin I. (1989) Pyridine toxins,Drugs for the treatment of Parkinson\u2019s Disease (Calne D. B., ed.), pp. 205\u2013226., Springer, Berlin-New York."},{"key":"BF03159935_CR142","first-page":"50","volume":"50","author":"F. H. Lewy","year":"1913","unstructured":"Lewy F. H. (1913) Zur pathologischen Anatomie der Paralysis agitans.Dtsch. Z. Nervenheilk. 50, 50\u201355.","journal-title":"Dtsch. Z. Nervenheilk."},{"key":"BF03159935_CR143","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-3565(25)11003-3","volume":"243","author":"S. J. Li","year":"1987","unstructured":"Li S. J., Sivam S. P., McGinty J. F., Huang Y. S. and Hong J. S. (1987) Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.J. Pharmacol. Exp. Ther. 243, 792\u2013798.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03159935_CR144","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1471-4159.1984.tb12812.x","volume":"43","author":"C. Llorens-Cortes","year":"1984","unstructured":"Llorens-Cortes C., Javoy-Agid F., Agid Y, Taquet H., and Schwartz J. C. (1984) Enkephalinergic markers in substantia nigra and caudate nucleus from parkinsonian subjects.J Neurochem. 43, 874\u2013877.","journal-title":"J Neurochem."},{"key":"BF03159935_CR145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0306-4522(86)90155-7","volume":"18","author":"S. E. Loughlin","year":"1986","unstructured":"Loughlin S. E., Foote S. L., and Bloom F. E. (1986) Efferent projections of nucleus locus coeruleus: Topographic organization of cells of origin demonstrated by three-dimensional reconstruction.Neuroscience 18, 291\u2013306.","journal-title":"Neuroscience"},{"key":"BF03159935_CR146","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-4943(89)90066-6","volume":"8","author":"P. Loew-Hummel","year":"1989","unstructured":"Loew-Hummel P., Gertz H.-J. Ferszt R., and Cervos-Navarro J. (1989) The basal nucleus of Meynert revisited.Arch. Gerontol. Geriatr. 8, 21\u201327.","journal-title":"Arch. Gerontol. Geriatr."},{"key":"BF03159935_CR147","first-page":"112","volume-title":"Drugs for the Treatment of Parkinson\u2019s Disease","author":"E. G. McGeer","year":"1989","unstructured":"McGeer E. G., and McGeer P. L. (1989) Biochemical neuroanatomy of the basal ganglia,Drugs for the Treatment of Parkinson\u2019s Disease (Calne D. B., ed.), pp. 112\u2013148,Handbook of Experimental Pharmacology vol. 88, Springer, Wien-New York."},{"key":"BF03159935_CR148","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.34.6.741","volume":"34","author":"P. L. McGeer","year":"1984","unstructured":"McGeer P. L., McGeer E. G., and Suzuki J. (1984) Aging, Alzheimer\u2019s disease, and the cholinergic system in the basal forebrain.Neurology 34, 741\u2013745.","journal-title":"Neurology"},{"key":"BF03159935_CR149","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.40.11.1739","volume":"40","author":"S. Malessa","year":"1990","unstructured":"Malessa S., Hirsch E. C., Cerver P., Duyckaerts C., and Agid Y. (1990) Catecholaminergic systems in the medulla oblongata in Parkinsonian syndromes. A quantitative immunohistochemical study in Parkinson\u2019s disease, progressive supranuclear palsy, and striatonigral degeneration.Neurology 40, 1739\u20131742.","journal-title":"Neurology"},{"key":"BF03159935_CR150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mds.870030310","volume":"3","author":"J. M. Maloteaux","year":"1988","unstructured":"Maloteaux J. M., Laterre E. C., Ladurot P. M., Javoy-Agid F., and Agid Y. (1988) Decrease of serotonin-R-2 receptors in temporal cortex of patients with Parkinson\u2019s disease and progressive supranuclear palsy.Movement Disord. 3, 255\u2013262.","journal-title":"Movement Disord."},{"key":"BF03159935_CR151","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1983.tb00320.x","volume":"9","author":"D. M. A. Mann","year":"1983","unstructured":"Mann D. M. A. and Yates P. O. (1983) Pathological basis for neurotransmitter changes in Parkinson\u2019s disease.Neuropathol Appl. Neurobiol. 9, 3\u201319.","journal-title":"Neuropathol Appl. Neurobiol."},{"key":"BF03159935_CR152","first-page":"147","volume":"5","author":"D. M. A. Mann","year":"1986","unstructured":"Mann D. M. A. and Yates P. O. (1986) Neurotransmitter deficits in Alzheimer\u2019s disease and other dementing disorders.Hum. Neurobiol. 5, 147\u2013156.","journal-title":"Hum. Neurobiol."},{"key":"BF03159935_CR153","first-page":"1","volume":"2","author":"D. M. A. Mann","year":"1983","unstructured":"Mann D. M. A., Yates P. O., and Hawkes J. (1983) The pathology of the human locus coeruleus.Clin. Neuropathol. 2, 1\u20137.","journal-title":"Clin. Neuropathol."},{"key":"BF03159935_CR154","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0047-6374(84)90140-4","volume":"25","author":"D. M. A. Mann","year":"1984","unstructured":"Mann D. M. A., Yates P. O., and Marcyniuk B. (1984) Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer\u2019s disease and their relationship to the accumulation of lipofuscin pigment.Mech. Ageing Dev. 25, 189\u2013204.","journal-title":"Mech. Ageing Dev."},{"key":"BF03159935_CR155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(85)90439-2","volume":"56","author":"D. M. A. Mann","year":"1985","unstructured":"Mann D. M. A., Yates P. O., and Marcyniuk B. (1985a) Correlation between senile plaques and neurofibrillary tangle counts in the cerebral cortex and neuron al counts in cortex and subcortical structures in Alzheimer\u2019s disease.Neurosci. Lett. 56, 51\u201355.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR156","first-page":"127","volume":"4","author":"D. M. A. Mann","year":"1985","unstructured":"Mann D. M. A., Yates P. O., and Marcyniuk B. (1985b) Changes in Alzheimer\u2019s disease in the magnocellular neurons of the supraoptic and paraventricular nuclei and their relationship to the noradrenergic deficit.Clin. Neuropathol. 4, 127.","journal-title":"Clin. Neuropathol."},{"key":"BF03159935_CR157","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jnnp.50.3.341","volume":"50","author":"D. M. A. Mann","year":"1987","unstructured":"Mann D. M. A., Yates P. O., and Marcyniuk B. (1987) Dopaminergic systems in Alzheimer\u2019s disease and Down\u2019s syndrome at middle age.J. Neurol. Neurosurg. Psychiatry 50, 341\u2013344.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR158","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3940(86)90336-8","volume":"64","author":"B. Marcyniuk","year":"1986","unstructured":"Marcyniuk B., Mann D. M. A., and Yates P. O. (1986) Loss of nerve cells from locus coeruleus in Alzheimer\u2019s disease is topographically arranged.Neurosci. Lett. 64, 247\u2013252.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR159","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0197-4580(89)80004-1","volume":"10","author":"B. Marcyniuk","year":"1989","unstructured":"Marcyniuk B., Mann D. M. A., and Yates P. O. (1989) The topography of nerve cell loss from the locus coeruleus in elderly persons.Neurobiol Aging 10, 5\u20139.","journal-title":"Neurobiol Aging"},{"key":"BF03159935_CR160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2990.1989.tb01222.x","volume":"15","author":"C. Masullo","year":"1989","unstructured":"Masullo C., Pocchiari M., Mariotti P., Macchi G., Garruto R. M., Gibbs C. J. Jr., et al. (1989) The nucleus basalis of Menyert in Parkinson-dementia of Guam: A morphometric study.Neuropathol. Appl. Neurobiol. 15, 193\u2013206.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BF03159935_CR161","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ana.410180507","volume":"18","author":"M. M. Matzuk","year":"1985","unstructured":"Matzuk M. M. and Saper C. B. (1985) Preservation of hypothalamic dopaminergic neurons in Parkinson\u2019s disease.Ann. Neurol. 18, 552\u2013555.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR162","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(83)90403-1","volume":"268","author":"A. Mauborgne","year":"1983","unstructured":"Mauborgne A., Javoy-Agid F., Legrand J. C., Agid Y., and Cesselin F. (1983) Decrease of substance P-like immunoreactivity in the substantia nigra and palidum of parkinsonian brains.Brain Res. 268, 167\u2013170.","journal-title":"Brain Res."},{"key":"BF03159935_CR163","first-page":"163","volume":"53","author":"R. Mayeux","year":"1990","unstructured":"Mayeux R. (1990) The \u201cserotonin hypothesis\u201d for depression in Parkinson\u2019s disease.Adv. Neurol. 53, 163\u2013166.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR164","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1192\/S0007125000291733","volume":"155","author":"H. Meltzer","year":"1989","unstructured":"Meltzer H. (1989) Serotonergic dysfunction in depression.Br. J. Psychiatry 155, 25\u201331.","journal-title":"Br. J. Psychiatry"},{"key":"BF03159935_CR165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cne.902750205","volume":"275","author":"M. M. Mesulam","year":"1988","unstructured":"Mesulam M. M., and Geula C. (1988) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase.J. Comp. Neurol. 275, 216\u2013260.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR166","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/brain\/107.1.253","volume":"107","author":"M. M Mesulam","year":"1984","unstructured":"Mesulam M. M and Mufson E. J. (1984) Neuronal inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey.Brain 107, 253\u2013274.","journal-title":"Brain"},{"key":"BF03159935_CR167","first-page":"94","volume-title":"Function and Dysfunction in the Basal Ganglia","author":"I. J. Mitchell","year":"1990","unstructured":"Mitchell I. J., Aambrook M. A., Jackson A., Clarke C. E., Robertson R. G., Boyce S., and Crossman A. R. (1990) Basal ganglia function in experimental movement disorders,Function and Dysfunction in the Basal Ganglia (Franks A. J. et al., eds.), pp. 94\u2013109, Manchester University Press, Manchester, NY."},{"key":"BF03159935_CR168","doi-asserted-by":"crossref","unstructured":"Mizutani T., Aki M., Shiozawa R., Tanabe H. Uchigata M. Oda M., Endo Y., and Hara M. (1991) Clinico-pathologic study of dementia in Parkinson\u2019s disease with special reference to degeneration of the locus ceruleus.Acta Neuropathol. (Berl.) 81, in press.","DOI":"10.1159\/000107210"},{"key":"BF03159935_CR169","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archneur.1988.00520270025015","volume":"45","author":"J. Moossy","year":"1988","unstructured":"Moossy J., Zubenko G. B., Martinez J., and Rao G. (1988) Bilateral symmetry of morphologic lesions in Alzheimer\u2019s disease.Arch. Neurol. 45, 251\u2013254.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR170","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ana.410240506","volume":"24","author":"E. J. Mufson","year":"1988","unstructured":"Mufson E. J., Mash D., and Hersh L. B. (1988) Neurofibrillary tangles in cholinergic pedunculopontine nucleus in Alzheimer\u2019s disease.Ann. Neurol. 24, 623\u2013629.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR171","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(91)90682-L","volume":"539","author":"E. J. Mufson","year":"1991","unstructured":"Mufson E. J., Presley L. N., and Kordower J. H. (1991) Nerve growth factor immunoreactivity with the nucleus basalis (Hc 4) in Parkinson disease. Reduced cell numbers and co-localization with cholinergic neurons.Brain Res. 539, 19\u201330.","journal-title":"Brain Res."},{"key":"BF03159935_CR172","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cne.902700108","volume":"270","author":"K. A. Mulligan","year":"1988","unstructured":"Mulligan K. A. and Tork I. (1988) Serotonergic innervation of the cat cerebral cortex.J. Comp. Neurol. 270, 86\u2013110.","journal-title":"J. Comp. Neurol."},{"key":"BF03159935_CR173","first-page":"207","volume":"53","author":"T. Nagatsu","year":"1990","unstructured":"Nagatsu T. (1990) Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP treated mice.Adv. Neurol. 53, 207\u2013214.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR174","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ana.410130118","volume":"13","author":"I. Nakano","year":"1984","unstructured":"Nakano I. and Hirano A. (1984) Neuron loss in the nucleus basalis of Meynert in Parkinson-dementia complex of Guam.Ann. Neurol. 13, 87\u201391.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-510X(84)90144-8","volume":"66","author":"S. Nakashima","year":"1984","unstructured":"Nakashima S. and Ikuta F. (1984) Tyrosine hydroxylase proteins in Lewy bodies of parkinsonism and senile brain.J. Neurol. Sci. 66, 91\u201396.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR176","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0167-0115(89)90254-1","volume":"25","author":"C. B. Nemeroff","year":"1989","unstructured":"Nemeroff C. B., Kizer J. S., Reynolds G. P., and Bisette G. (1989) Neuropeptides in Alzheimer\u2019s disease: A postmortem study.Regul. Pept. 25, 123\u2013130.","journal-title":"Regul. Pept."},{"key":"BF03159935_CR177","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-10343-2","volume-title":"The Human Central Nervous System. A Synopsis and Atlas","author":"R. Nieuwenhuys","year":"1988","unstructured":"Nieuwenhuys R., Voogd J., and Van Huijzen C. (1988)The Human Central Nervous System. A Synopsis and Atlas 3rd Ed., (Springer, Berlin).","edition":"3rd Ed."},{"key":"BF03159935_CR178","volume-title":"Cytoarchitecture of the Human Brain Stem","author":"J. Olszewski","year":"1982","unstructured":"Olszewski J. and Baxter D. (1982)Cytoarchitecture of the Human Brain Stem 2nd Ed. (Karger, Basel, New York).","edition":"2nd Ed."},{"key":"BF03159935_CR179","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-8993(87)90018-7","volume":"414","author":"A. M. Palmer","year":"1987","unstructured":"Palmer A. M., Francis P. T., Bowen D. M., Benton J. S., Neary D., Mann D. M., and Swanson J. S. (1987) Catecholaminergic neurons assessed ante-mortem in Alzheimer\u2019s disease.Brain Res. 414, 365\u2013375.","journal-title":"Brain Res."},{"key":"BF03159935_CR180","doi-asserted-by":"crossref","unstructured":"Paulus W. and Jellinger K. (1991) The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease.J. Neuropathol Exp. Neurol., in press.","DOI":"10.1097\/00005072-199111000-00006"},{"key":"BF03159935_CR181","first-page":"139","volume":"24","author":"R. C. A. Pearson","year":"1987","unstructured":"Pearson R. C. A., and Powell T. P. S. (1987) Anterograde vs retrograde degeneration of the nucleus basalis medialis in Alzheimer\u2019s disease.J. Neural Transm. (Suppl.) 24, 139\u2013146.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03159935_CR182","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0006-8993(83)90046-X","volume":"289","author":"R. C. A. Pearson","year":"1983","unstructured":"Pearson R. C. A., Sofroniew M. V., Cuello A. C., Powell T. P., Eckenstein, F., Esiri M. M., and Wilcock G. K. (1983) Persistence of cholinergic neurons in the basal nucleus of a brain with senile dementia of the Alzheimer\u2019s type.Brain Res. 289, 375\u2013379.","journal-title":"Brain Res."},{"key":"BF03159935_CR183","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02257646","volume":"2","author":"E. K. Perry","year":"1990","unstructured":"Perry E. K., Smith C. J., Court J. A., and Perry R. H. (1990a) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.J Neural Transm. (P-D Sect.) 2, 149\u2013158.","journal-title":"J Neural Transm. (P-D Sect.)"},{"key":"BF03159935_CR184","first-page":"117","volume":"5","author":"E. K. Perry","year":"1989","unstructured":"Perry E. K., Smith C. J., Perry R. H., Johnson M., and Fairbairn A. F. (1989) Nicotinic (3H-nicotine) receptor binding in human brain: Characterization and involvement in cholinergic neuropathology.Neurosci. Res. Commun. 5, 117\u2013124.","journal-title":"Neurosci. Res. Commun."},{"key":"BF03159935_CR185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","volume":"48","author":"E. K. Perry","year":"1985","unstructured":"Perry E. K., Curtis M., Dick D. J., Atack J. H, Bloxham C. A., Blessed G., Fairbairn A., Tomlinson B. E., and Perry R. H. (1985) Cholinergic correlates of cognitive impairment in Parkinson\u2019s disease: Comparison with Alzheimer\u2019s disease.J. Neurol. Neurosurg. Psychiatry 48, 413\u2013421.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR186","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-510X(81)90106-4","volume":"51","author":"E. K. Perry","year":"1981","unstructured":"Perry E. K., Tomlinson B. E., Blessed G., Perry R. H., Cross A. J., and Crow T. J. (1981) Neuropathological and biochemical observations on the noradrenergic system in Alzheimer\u2019s disease.J. Neurol. Sci. 51, 279\u2013287.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR187","first-page":"45","volume":"42","author":"R. H. Perry","year":"1986","unstructured":"Perry R. H. (1986) Alzheimer\u2019s disease: Recent advances in neuropathology.Br. Med. Bull. 42, 45\u201350.","journal-title":"Br. Med. Bull."},{"key":"BF03159935_CR188","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-510X(90)90236-G","volume":"95","author":"R. H. Perry","year":"1990","unstructured":"Perry R. H., Irving D., Blessed G., Fairbairn A. F., and Perry E. K. (1990b) Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.J. Neurol. Sci. 95, 119\u2013139.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR189","first-page":"311","volume":"2","author":"R. H. Perry","year":"1983","unstructured":"Perry R. H., Tomlinson B. E., Candy J. M., Blessed G., Foster J. F., Bloxham C. A., and Perry E. R. (1983) Cortical cholinergic deficit in mentally impaired Parkinsonian patients.Lancet 2, 311\u2013315.","journal-title":"Lancet"},{"key":"BF03159935_CR190","first-page":"131","volume":"24","author":"R. H. Perry","year":"1987","unstructured":"Perry R. H., Perry E. K., Smith C. J., Xuereb J. H., Irving D., Whitford C. A. Candy J. M., and Cross A. J. (1987) Cortical neuropathological and neurochemical substrates of Alzheimer\u2019s and Parkinson\u2019s disease.J. Neural Transm. (Suppl.) 24, 131.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03159935_CR191","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(88)91558-2","volume":"450","author":"A. Probst","year":"1988","unstructured":"Probst A., Cortex R., Ulrich J., and Palacios J. M. (1988) Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer\u2019s disease: An autoradiographic study.Brain Res. 450, 190\u2013201.","journal-title":"Brain Res."},{"key":"BF03159935_CR192","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S0317167100037215","volume":"13","author":"R. Quirion","year":"1986","unstructured":"Quirion R., Martel J. C., Robitaille Y. Etienne P., Wood P., Nair N. P. V. and Gauthier S. (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.Can. J. Neurol. Sci. 13, 503\u2013510.","journal-title":"Can. J. Neurol. Sci."},{"key":"BF03159935_CR193","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0306-4522(89)90291-1","volume":"32","author":"G. Ransmayer","year":"1989","unstructured":"Ransmayer G., Cervera P., Hirsch E. Ruberg M., Hersh L. B., Duyckaerts C., Hauw J. J., Deluneau F., and Agid Y. (1989) Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer\u2019s disease.Neuroscience 32, 701\u2013714.","journal-title":"Neuroscience"},{"key":"BF03159935_CR194","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/brain\/112.5.1193","volume":"112","author":"O. Rascol","year":"1989","unstructured":"Rascol O., Clanet M., Motastruc J. L., Simonetta M., Soulier-Esteve M. J., Doyon B., and Rascol A. (1989) Abnormal ocular movements in Parkinson\u2019s disease.Brain 112, 1193\u20131214.","journal-title":"Brain"},{"key":"BF03159935_CR195","first-page":"293","volume":"82","author":"M. S. Reid","year":"1990","unstructured":"Reid M. S., Herrera-Marschitz M., H\u00f6kfelt T., Lindefors N., Persson H., and Ungerstedt U. (1990) Striatonigral GABA dynorphin, substance P and neurokinin-A modulation of nigrostriatal release. Evidence for direct regulatory mechanisms.Exp. Brain Res. 82, 293\u2013304.","journal-title":"Exp. Brain Res."},{"key":"BF03159935_CR196","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(88)90179-7","volume":"84","author":"R. Reinikainen","year":"1988","unstructured":"Reinikainen R., Palj\u00e4rvi L., and Huusekonnen M. (1988b) A postmortem study of noradrenergic, serotonergic and GABAergic neurones in Alzheimer\u2019s disease.J. Neurol. Sci. 84, 101\u2013115.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR197","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00973325","volume":"13","author":"K. J. Reinikainen","year":"1988","unstructured":"Reinikainen K. J., Riekkinen P. J., and Palj\u00e4rvi L (1988a) Cholinergic deficit in Alzheimer\u2019s disease: A study based on CSF and autopsy data.Neurochem. Res. 13, 135\u2013146.","journal-title":"Neurochem. Res."},{"key":"BF03159935_CR198","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(87)90120-X","volume":"403","author":"G. A. Ricaurte","year":"1987","unstructured":"Ricaurte G. A., Irwin I., Forno L. S., DeLanney L. E., Langston E. B., and Langston J. W. (1987) Aging and MPTP-induced degeneration of dopaminergic neurons in the substantia nigra.Brain Res. 403, 43\u201351.","journal-title":"Brain Res."},{"key":"BF03159935_CR199","first-page":"121","volume":"14","author":"P. Riederer","year":"1978","unstructured":"Riederer P., Rausch W. D., Birkmayer W., Jellinger K., and Seeman D. (1978) CNS modulation of adrenal tyrosine hydroxylase in Parkinson\u2019s disease and metabolic encephalopathies.J. Neural Transm. (Suppl.) 14, 121\u2013133.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03159935_CR200","first-page":"1","volume-title":"The Role of Brain Dopamine","author":"P. Riederer","year":"1990","unstructured":"Riederer P., Sofic E., Konradi C., Kornhuber J., Beckmann H., Dietl M., Moll G., and Hebenstreit G. (1990) The role of dopamine in the control of neurobiological functions,The Role of Brain Dopamine (Fl\u00fcckinger E., M\u00fcller E. E., and Thorner M. O., eds.), pp. 1\u201317, Springer, Berlin."},{"key":"BF03159935_CR201","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-510X(87)90260-7","volume":"79","author":"J. O. Rinne","year":"1987","unstructured":"Rinne J. O., Palj\u00e4rvi L., and Rinne U. K. (1987) Neuronal size and density in the nucleus basalis Meynert in Alzheimer\u2019s disease.J. Neurol. Sci. 79, 67\u201376.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR202","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0006-8993(89)90188-1","volume":"483","author":"J. O. Rinne","year":"1989","unstructured":"Rinne J. O., L\u00f6nnberg P., Marjam\u00e4ki P., and Rinne U. K. (1989b) Brain muscarinic receptor subtypes are differentially affected in Alzheimer\u2019s disease and Parkinson\u2019s disease.Brain Res. 483, 402\u2013406.","journal-title":"Brain Res."},{"key":"BF03159935_CR203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.410260107","volume":"26","author":"J. O. Rinne","year":"1989","unstructured":"Rinne J. O., Rummukainien J., Palj\u00e4rvi L., and Rinne U. K. (1989a) Dementia in Parkinson\u2019s disease is related to neuronal loss in the medial substantia nigra.Ann. Neurol. 26, 47\u201350.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR204","first-page":"163","volume":"19","author":"U. K. Rinne","year":"1983","unstructured":"Rinne U. K., Rinne J. K., Rinne J. O., Laakso K., Tenovuo L., L\u00f6nnberg P., Koskinen V. (1983) Brain enkephalin receptors in Parkinson\u2019s disease.J. Neural Transm. (Suppl.) 19, 163\u2013171.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03159935_CR205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.410170210","volume":"17","author":"J. D. Rogers","year":"1985","unstructured":"Rogers J. D., Brogan D., and Mirra S. S. (1985) The nucleus basalis Meynert in neurological disease: A quantitative morphological study.Ann. Neurol. 17, 163.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR206","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.288.6422.961","volume":"288","author":"M. N. Rossor","year":"1984","unstructured":"Rossor M. N., Iversen L. I., and Reynolds G. P. (1984) Neurochemical characteristics of early and late onset types of Alzheimer\u2019s disease.Br. Med. J. 288, 961\u2013964.","journal-title":"Br. Med. J."},{"key":"BF03159935_CR207","volume-title":"Handbook of Psychopharmacology","author":"M. Ruberg","year":"1988","unstructured":"Ruberg M. and Agid Y. (1988) Dementia in Parkinson\u2019s disease,Handbook of Psychopharmacology, vol. 20 (Iversen L., et al., eds.), Plenum, New York."},{"key":"BF03159935_CR208","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410180503","volume":"18","author":"M. Ruberg","year":"1985","unstructured":"Ruberg M., Javoy-Agid F., Hirsch E., Scatton B., LHeureux R., Hauw J. J., Duyckaerts C., Gray F., Morel-Maroger A., and Rascol A. (1985) Dopaminergic and cholinergic lesions in progressive supranuclear palsy.Ann. Neurol. 18, 523\u2013529.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR209","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0006-291X(84)80381-2","volume":"125","author":"J. L. Sadoul","year":"1984","unstructured":"Sadoul J. L., Checler F., Kitabki P., Rostene W., Javoy-Agid F., and Vincent J. P. (1984) Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects.Biochem. Biophys. Res. Commun. 125, 395\u2013404.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03159935_CR210","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/WNL.35.8.1089","volume":"35","author":"C. B. Saper","year":"1985","unstructured":"Saper C. B., German D. C., and White C. L. (1985) Neuronal pathology in the nucleus basalis of Meynert and associated cell groups in senile dementia of the Alzheimer\u2019s type. Possible role in cell loss.Neurology 35, 1089\u20131095.","journal-title":"Neurology"},{"key":"BF03159935_CR211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3940(87)90664-1","volume":"79","author":"E. Scarnati","year":"1987","unstructured":"Scarnati E., Gasbarri A., Campana E., and Pacitti C. (1987) The organization of the nucleus tegmenti pedunculopontine neurons projecting to basal ganglia and thalamus.Neurosci. Lett. 79, 11\u201316.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(86)91446-0","volume":"380","author":"B. Scatton","year":"1986","unstructured":"Scatton B., Dennis T., L\u2019Heureux R., Montofort J., Duyckaerts C., and Javoy-Agid F. (1986) Degeneration of noradrenergic and serotonergic but not dopaminergic neurons in lumbar spinal cord of parkinsonian patients.Brain Res. 380, 181\u2013185.","journal-title":"Brain Res."},{"key":"BF03159935_CR213","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0006-8993(87)90691-3","volume":"411","author":"J. S. Schneider","year":"1987","unstructured":"Schneider J. S., Yuwiler A., and Markham C. H. (1987) Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.Brain Res. 411, 144\u2013150.","journal-title":"Brain Res."},{"key":"BF03159935_CR214","doi-asserted-by":"crossref","unstructured":"Shin R.-W., Kitamoto T., and Tateishi J. (1991) Modified tau is present in younger nondemented persons: A study of subcortical nuclei in Alzheimer\u2019s disease and progressive supranuclear palsy.Acta Neuropathol. (Berl.) 81, in press.","DOI":"10.1007\/BF00310132"},{"key":"BF03159935_CR215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-510X(89)90042-7","volume":"90","author":"J. Sirvio","year":"1989","unstructured":"Sirvio J., Rinne J. O., Valjakka A., Rinne U. K., Riekkinen P. J., and Palj\u00e4rvi L. (1989) Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson\u2019s disease.J. Neurol. Sci. 90, 23\u201332.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR216","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-642-72922-5_29","volume-title":"Biologische Psychiatrie. Synopsis 1986\/87","author":"E. Sofic","year":"1988","unstructured":"Sofic E., Moll G., Riederer P., Jellinger K., and Gabriel E. (1988) Monoaminerge L\u00e4sion bei seniler Demenz vom Alzheimer-Typ (SDAT).Biologische Psychiatrie. Synopsis 1986\/87 (Beckmann H., and Laux G., eds.), pp. 151\u2013157, Springer, Berlin."},{"key":"BF03159935_CR217","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneur.1988.00520330084014","volume":"45","author":"D. L. Sparks","year":"1988","unstructured":"Sparks D. L., DeKosky S. T., and Markesberry W. (1988) Alzheimer\u2019s disease. Aminergic-cholinergic alterations in hypothalamus.Arch. Neurol. 45, 994\u2013999.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR218","first-page":"68","volume-title":"Handbook of Chemical Neuroanatomy, vol. 3: Classical Transmitters and Transmitter Receptors in CNS, Part II","author":"H. W. M. Steinbush","year":"1984","unstructured":"Steinbush H. W. M. (1984) Serotonin-immunoreactive neurons and their projections in the CNS,Handbook of Chemical Neuroanatomy, vol. 3: Classical Transmitters and Transmitter Receptors in CNS, Part II (Bj\u00f6rklund A., H\u00f6kfelt T., and Kuhar M. J., eds.), pp. 68\u2013125, Elsevier, Amsterdam-New York."},{"key":"BF03159935_CR219","doi-asserted-by":"crossref","unstructured":"Steriade M. and Biesold D. (1990)Brain Cholinergic Systems, Oxford University Press.","DOI":"10.1093\/oso\/9780198542667.001.0001"},{"key":"BF03159935_CR220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1749-6632.1985.tb29979.x","volume":"448","author":"J. M. Studler","year":"1985","unstructured":"Studler J. M. and Javoy-Agid F. (1985) Cholecystokinin octapeptide immunoreactivity distribution in human brain.Ann. NY Acad. Sci. 448, 656\u2013659.","journal-title":"Ann. NY Acad. Sci."},{"key":"BF03159935_CR221","doi-asserted-by":"crossref","unstructured":"Swaab D. F., Fliers E., and Goudsmit E. (1986) Differential cell loss in (peptide) neurons in the anterior hypothalamus with aging and Alzheimer\u2019s disease,Neurology (Poeck K., Freund H. J., G\u00e4nshirt H., eds.), p. 119\u2013125, Springer.","DOI":"10.1007\/978-3-642-70007-1_14"},{"key":"BF03159935_CR222","first-page":"624","volume":"9","author":"L. W. Swanson","year":"1982","unstructured":"Swanson L. W. (1982) Normal hippocampal circuitry.Neurosci. Res. Progr. Bull. 9, 624\u2013637.","journal-title":"Neurosci. Res. Progr. Bull."},{"key":"BF03159935_CR223","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00690198","volume":"68","author":"M. Tabaton","year":"1985","unstructured":"Tabaton M., Schenone A., Romagnoli P., and Mancardi G. L. (1985) A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer\u2019s disease.Acta Neuropathol. (Berl.) 68, 218\u2013223.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR224","doi-asserted-by":"crossref","unstructured":"Tagliavini F. and Pilleri G. (1984) The basal nucleus of Meynert in cerebral aging and degenerative dementias,Brain Pathology (Tagliavini F. and Pilleri G., eds.), The basal nucleus of Meynert in cerebral aging and degenerative dementias,Brain Pathology (Tagliavini F. and Pilleri G., eds.), vol. 1, pp. 181\u2013218. Bern.","DOI":"10.1016\/0022-510X(83)90203-4"},{"key":"BF03159935_CR225","unstructured":"Tagliavini F., Pilleri G., Bouraas C., and Constantinidis J. (1984) The nucleus basalis of Meynert in cerebral aging and degenerative dementias,Brain Pathology (Tagliavini F., and Pilleri G., eds.) pp. 181\u2013218. Bern."},{"key":"BF03159935_CR226","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(85)91081-9","volume":"341","author":"H. Taquet","year":"1985","unstructured":"Taquet H., Javoy-Agid F., Giraud P., Legrand J. D., Agid Y., and Cesselin F. (1985) Dynorphin levels in parkinsonian patients.Brain Res. 341, 390\u2013392.","journal-title":"Brain Res."},{"key":"BF03159935_CR227","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0143-4179(88)90039-X","volume":"12","author":"H. Taquet","year":"1988","unstructured":"Taquet H., Nomoto M., Rose S., Jenner P., Javoy-Agid F., Mauborgne A., Benoliel J. J., Marsden C. D., Legrand J. C., Agid Y., Hamon M., and Cesselin F. (1988) Levels of MET-Enkephalin, LEU-Enkephalin, Substance P and Cholecystokinin in the Brain of the Common Marmoset Following Long Term 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment.Neuropeptides 12, 105\u2013110.","journal-title":"Neuropeptides"},{"key":"BF03159935_CR228","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(84)90217-8","volume":"303","author":"O. Tenovuo","year":"1984","unstructured":"Tenovuo O., Rinne J. K., and Viljanen M. K. (1984) Substance P immunoreactivity in post-mortem parkinsonian brain.Brain Res. 303, 113\u2013116.","journal-title":"Brain Res."},{"key":"BF03159935_CR229","first-page":"145","volume":"53","author":"O. Tenovuo","year":"1990","unstructured":"Tenovuo O., Kolhinen A., Laihinen A., and Rinne U. K. (1990) Brain substance P receptors in Parkinson\u2019s disease.Adv. Neurol. 53, 145\u2013148.","journal-title":"Adv. Neurol."},{"key":"BF03159935_CR230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00005072-199005000-00176","volume":"49","author":"R. D. Terry","year":"1990","unstructured":"Terry R. D., Masliah E., Salmon D., and DeTeresa H. (1990) Structure-function correlations in Alzheimer\u2019s disease (abstract).J. Neuropathol. Exp. Neurol. 49, 318.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR231","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2990.1989.tb01250.x","volume":"15","author":"B. E. Tomlinson","year":"1989","unstructured":"Tomlinson B. E. (1989) The neuropathology of Alzheimer\u2019s disease\u2014issues in need of resolution.Neuropathol. Appl. Neurobiol. 15, 491\u2013512.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BF03159935_CR232","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0022-510X(81)90031-9","volume":"49","author":"B. E. Tomlinson","year":"1981","unstructured":"Tomlinson B. E., Irving D., and Blessed G. (1981) Cell loss in the locus coeruleus in senile dementia of the Alzheimer type.J. Neurol. Sci. 49, 419\u2013428.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR233","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00313699","volume":"230","author":"M. Tomonoga","year":"1983","unstructured":"Tomonoga M. (1983) Neuropathology of the locus coeruleus: A semiquantitative study.J. Neurol. 230, 231\u2013240.","journal-title":"J. Neurol."},{"key":"BF03159935_CR234","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.1986.00520100078018","volume":"43","author":"R. M. Torack","year":"1986","unstructured":"Torack R. M. and Morris J. C. (1986) Mesocorticolimbical dementia.Arch. Neurol. 43, 1074\u20131078.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archneur.1988.00520290025008","volume":"45","author":"R. M. Torack","year":"1988","unstructured":"Torack R. M. and Morris J. C. (1988) The association of ventral tegmental area histopathology with adult dementia.Arch. Neurol. 45, 497\u2013501.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR236","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/WNL.35.8.1215","volume":"35","author":"G. R. Uhl","year":"1985","unstructured":"Uhl G. R., Hedreen J. C., and Price D. L. (1985) Parkinson\u2019s disease: Loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions.Neurology 35, 1215\u20131218.","journal-title":"Neurology"},{"key":"BF03159935_CR237","first-page":"99","volume":"12","author":"G. R. Uhl","year":"1982","unstructured":"Uhl G. R., McKinney M., Hedreen J. C., White C. L., Coyle J. T., Whitehouse P. J., and Price D. L. (1982) Dementia pugilistica: Loss of basal forebrain cholinergic neurons and cortical cholinergic markers.Ann. Neurol. 12, 99\u2013102.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR238","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0168-0102(89)90007-2","volume":"6","author":"N. Ulfig","year":"1989","unstructured":"Ulfig N. (1989) Altered lipofuscin pigmentation in the basal nucleus (Meynert) in Parkinson\u2019s disease.Neurosci. Res. 6, 456\u2013462.","journal-title":"Neurosci. Res."},{"key":"BF03159935_CR239","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.53.6.492","volume":"53","author":"M. A. Verity","year":"1990","unstructured":"Verity M. A. Roitberg B. and Kepes J. J. (1990) Mesolimbicocortical dementia: Clinico-pathological studies on two cases.J. Neurol. Neurosurg. Psychiatry 53, 492\u2013495.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR240","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00005072-197909000-00004","volume":"38","author":"N. Vijayshankar","year":"1979","unstructured":"Vijayshankar N. and Brody H. (1979) A quantitative study of pigmented neurons in the nuclei locus coeruleus and subcoeruleus in man as related to aging.J. Neuropathol. Exp. Neurol. 38, 490\u2013497.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03159935_CR241","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-3940(90)90538-K","volume":"109","author":"O. J. M. Vogels","year":"1990","unstructured":"Vogels O. J. M., Broere C. A. J., and Nieuwenhuys R. (1990a) Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer\u2019s disease.Neurosci. Lett. 109, 62\u201367.","journal-title":"Neurosci. Lett."},{"key":"BF03159935_CR242","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0197-4580(90)90056-6","volume":"11","author":"O. J. M. Vogels","year":"1990","unstructured":"Vogels O. J. M., Broere C. A. J., Ter Laak H. J., Ten Donkellar H. J., Nieuwenhuys R. and Schulte B. M. (1990b) Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer\u2019s disease.Neurobiol. Aging 11, 3\u201313.","journal-title":"Neurobiol. Aging"},{"key":"BF03159935_CR243","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K. Wakabayashi","year":"1988","unstructured":"Wakabayashi K., Takahashi H., Takeda S., Ohama E., and Ikuta F. (1988) Parkinson\u2019s disease: The presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses.Acta Neuropathol. (Berl.) 76, 217\u2013221.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR244","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-4522(88)90249-7","volume":"25","author":"C. M. Waters","year":"1988","unstructured":"Waters C. M., Peck P., Rossor M., Reynolds G. P., and Hunt S. P. (1988) Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson\u2019s disease and Huntington\u2019s chora.Neuroscience 25, 419\u2013438.","journal-title":"Neuroscience"},{"key":"BF03159935_CR245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.3875898","volume":"230","author":"K. N. Westlund","year":"1985","unstructured":"Westlund K. N., Denney R. M., Kochersberger L. M., Rose R. M., and Abell C. W. (1985) Distinct monoamine oxidase A and B populations in primate brain.Science 230, 181\u2013183.","journal-title":"Science"},{"key":"BF03159935_CR246","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-4522(88)90250-3","volume":"25","author":"K. N. Westlund","year":"1988","unstructured":"Westlund K. N., Denney R. M., Rose R., and Abell C. M. (1988) Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem.Neuroscience 25, 439\u2013456.","journal-title":"Neuroscience"},{"key":"BF03159935_CR247","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/brain\/106.3.555","volume":"106","author":"O. B. White","year":"1983","unstructured":"White O. B., Saint-Cyr J. A., Tomlinson R. D., and Sharpe J. A. (1983) Ocular motor deficits in Parkinson\u2019s disease. I and II.Brain 106, 555\u2013587.","journal-title":"Brain"},{"key":"BF03159935_CR248","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","volume":"13","author":"P. J. Whitehouse","year":"1983","unstructured":"Whitehouse P. J., Hedreen J. C., White C. L., and Price D. L. (1983) Basal forebrain neurons in the dementia of Parkinson\u2019s disease.Ann. Neurol. 13, 243\u2013248.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR249","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1212\/WNL.37.6.905","volume":"37","author":"P. J. Whitehouse","year":"1987","unstructured":"Whitehouse P. J., Vale W. W., Zweig R. M., Singer H. S., Mayeux R., Kuhar M. J., Price D. L., and DeSouza E. B. (1987) Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer\u2019s disease, Parkinson\u2019s disease and progressive supranuclear palsy.Neurology 37, 905\u2013909.","journal-title":"Neurology"},{"key":"BF03159935_CR250","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.38.5.720","volume":"38","author":"P. J. Whitehouse","year":"1988","unstructured":"Whitehouse P. J., Martino A. M., Wagster M. V., Price M. L., Mayeux R., Atack J. R., and Kellar K. J. (1988) Reductions in [3H]nicotinic acetylcholine binding in Alzheimer\u2019s disease and Parkinson\u2019s disease: An autoradiographic study.Neurology 38, 720\u2013723.","journal-title":"Neurology"},{"key":"BF03159935_CR251","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-510X(88)90003-2","volume":"86","author":"C. Whitford","year":"1988","unstructured":"Whitford C., Candy J., Edwardson J., and Perry J. (1988) Cortical somatostatinergic system not affected in Alzheimer\u2019s and Parkinson\u2019s diseases.J. Neurol. Sci. 86, 13\u201318.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR252","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/jnnp.51.6.842","volume":"51","author":"G. K. Wilcock","year":"1988","unstructured":"Wilcock G. K., Esiri M. M., Bowen D., and Hughes A. O. (1988) The differential involvement of subcortical nuclei in senile dementia of the Alzheimer type.J. Neurol. Neurosurg. Psychiatry 51, 842\u2013849.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BF03159935_CR253","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(90)90155-G","volume":"99","author":"J. H. Xuereb","year":"1990","unstructured":"Xuereb J. H., Perry E. K., Candy J. M., Bonham J. R., Perry R. H., and Marschall E. (1990) Parameters of cholinergic neurotransmission in the thalamus in Parkinson\u2019s disease and Alzheimer\u2019s disease.J. Neurol. Sci. 99, 185\u2013197.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR254","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91236-A","volume":"526","author":"T. Yamada","year":"1990","unstructured":"Yamada T., McGeer P. L., Baimbridge K. G., and McGeer E. G. (1990) Relative sparing in Parkinson\u2019s disease of substantia nigra dopamine neurons containing calbinding D 28K.Brain Res. 526, 303\u2013307.","journal-title":"Brain Res."},{"key":"BF03159935_CR255","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00687815","volume":"67","author":"T. Yamamoto","year":"1985","unstructured":"Yamamoto T. and Hirano A. (1985) Nucleus raphe dorsalis in Parkinson\u2019s dementia complex of Guam.Acta Neuropathol. (Berl.) 67, 296\u2013299.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR256","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0022-510X(85)90157-1","volume":"67","author":"C. M. Yates","year":"1984","unstructured":"Yates C. M., Fink G. M., Bennie J. G., Gordon A., Simpson J., and Eskay R. L. (1984) Neurotensin immunoreactivity in post-mortem brain is increased in Down\u2019s syndrome but not in Alzheimer-type dementia.J. Neurol. Sci. 67, 327\u2013335.","journal-title":"J. Neurol. Sci."},{"key":"BF03159935_CR257","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF00688953","volume":"68","author":"M. Zech","year":"1985","unstructured":"Zech M. and Bogerts B. (1985) Methionine, enkephalin and substance P in the basal ganglia of schizophrenics: A quantitative immunohistochemical comparison with Huntington and Parkinson patients.Acta Neuropathol. (Berl.) 68, 32\u201338.","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"BF03159935_CR258","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.1990.00530020117023","volume":"47","author":"G. S. Zubenko","year":"1990","unstructured":"Zubenko G. S., Moossy J., and Kopp U. (1990) Neurochemical correlates of major depression in primary dementia.Arch. Neurol. 47, 209\u2013214.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR259","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneur.1988.00520270029016","volume":"45","author":"G. S. Zubenko","year":"1988","unstructured":"Zubenko G. S., Moossy J., Hanin I., Martinez A. J., Rao G. R., and Kopp G. R. (1988) Bilateral symmetry of cholinergic deficits in Alzheimer\u2019s disease.Arch. Neurol. 45, 255\u2013259.","journal-title":"Arch. Neurol."},{"key":"BF03159935_CR260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410260106","volume":"26","author":"R. M. Zweig","year":"1989","unstructured":"Zweig R. M., Jankel W. R., Hedreen J. C., Mayeux R., and Price D. L. (1989a) The pedunculopontine nucleus in Parkinson\u2019s disease.Ann. Neurol. 26, 41\u201346.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR261","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.410240210","volume":"24","author":"R. M. Zweig","year":"1988","unstructured":"Zweig R. M., Rose C. A., Hedreen J. C., Steele C., Cardillo J. E., Whitehouse P. J., Folstein M. F., and Price D. L. (1988a) The neuropathology of aminergic nuclei in Alzheimer\u2019s disease.Ann. Neurol. 24, 233\u2013242.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR262","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.410240210","volume":"24","author":"R. M. Zweig","year":"1988","unstructured":"Zweig R. M., Ross C. A., Peyser C., Cardillo J. E., Coehn M., Folstein S., and Price D. L. (1988b) The locus ceruleus and dementia in Parkinson\u2019s disease and Huntington\u2019s disease.Ann. Neurol. 24, 133.","journal-title":"Ann. Neurol."},{"key":"BF03159935_CR263","first-page":"353","volume-title":"Alzheimer\u2019s disease and related disorders","author":"R. M. Zweig","year":"1989","unstructured":"Zweig R. M., Ross C. A., Hedreen J. C., Steele C., Cardillo J. E., Whitehouse P. J., Folstein M. F., and Price D. L. (1989b) Neuropathology of aminergic nuclei in Alzheimer\u2019s disease,Alzheimer\u2019s disease and related disorders (Iqbal K., and Wisniewski H. M., eds.) pp. 353\u2013365, A. R. Liss, New York."}],"container-title":["Molecular and Chemical Neuropathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03159935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03159935\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03159935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T20:22:08Z","timestamp":1739305328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03159935"}},"subtitle":["Changes other than the nigrostriatal pathway"],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":263,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["BF03159935"],"URL":"https:\/\/doi.org\/10.1007\/bf03159935","relation":{},"ISSN":["1044-7393"],"issn-type":[{"value":"1044-7393","type":"print"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}